207.62MMarket Cap-1697P/E (TTM)
11.3900High10.2700Low683.36KVolume11.3200Open11.1600Pre Close7.29MTurnover4.21%Turnover RatioLossP/E (Static)19.99MShares21.660052wk High1.14P/B168.67MFloat Cap6.500052wk Low--Dividend TTM16.24MShs Float128.4400Historical High--Div YieldTTM10.04%Amplitude6.5000Historical Low10.6670Avg Price1Lot Size
Cybin Stock Forum
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$
$NVIDIA (NVDA.US)$ $Tesla (TSLA.US)$ $SoFi Technologies (SOFI.US)$
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
Cybin Inc. (NYSE American:CYBN)reported groundbreaking 12-month efficacy data from its Phase 2 study of CYB003 for major depressive disorder (MDD). After two 16mg doses administered three weeks apart, 100% of participants were responsive to treatment, with 71% in remission at 12 months. The study showed a ~23-point reduction in MADRS depression s...
EXCLUSIVE: Cybin Tells Benzinga Co. Announces Grant Of First U.S Composition of Matter Patent N Support Of Its CYB005 Phenethylamines Program
No comment yet